Connect with us

IT Industry

RYAH Medtech announces CE Mark for its RYAH vaporizer to establish critical plant-based dose measuring and data analytics in the European market

GlobeNewswire

Published

on

Reading Time: 4 minutes

NEW YORK, June 20, 2019 (GLOBE NEWSWIRE) — RYAH Medtech Inc. (“RYAH” or the “Company”), announced today that it has received a CE Mark for its dose measuring and data aggregator vaporizer. The certification is a critical part of RYAH’s expansion strategy in the European region for the RYAH dose-measuring plant-based vaporizer, RYAH proprietary dry herb cartridges, and real-time data analytics solution.

“Countries around the world are embracing the health benefits of dry herb medicine, and we believe the RYAH vaporizer will be an essential tool to add legitimacy to the international market. The user-generated, HIPAA-compliant data that RYAH collects is expected to be instrumental in enabling physicians to make educated recommendations to help patients optimize their relief and avoid possible negative experiences from medicating with plant-based medicine. The CE mark of the RYAH vaporizer is an important milestone for RYAH’s global aspirations and we expect to shortly initiate our launch in Europe,” says Jordan Medley, Head of Product Operations at RYAH.

According to Prohibition Partners’ “The European Cannabis Report, 2019”; Europe’s cannabis market is estimated to be worth up to €123b by 2028, led by medicinal treatments. The report highlights that Europe will likely become the world’s largest legal plant-based treatment market over the next five years. RYAH plans to roll-out several other clinical delivery mechanisms for dose measuring and data collection, including an oil delivery capability, state-of-the-art transdermal patch, tincture pen, and multi-cartridge mechanisms – all using groundbreaking technologies in conjunction with RYAH’s data aggregators.

About RYAH Medtech, Inc.

RYAH is a big data and technology company focused on valuable predictive analysis in the global medical plant intake industry. Its robust artificial intelligence platform aggregates and correlates HIPAA-compliant medical data, which is intended to help doctors and patients personalize plant-based treatments to better predict treatment outcomes. The data collection is also relevant for growers, dispensaries and Licensed Processors (LPs) to monitor and manage plant strain effects on patients. With a strong IP portfolio, RYAH gathers deep and insightful data on the complete medical plant lifecycle, from seed to consumption.

Forward-Looking Statements

Certain statements contained in this press release constitute “forward-looking information” as such term is defined in applicable Canadian securities legislation. The words “may”, “would”, “could”, “should”, “potential”, “will”, “seek”, “intend”, “plan”, “anticipate”, “believe”, “estimate”, “expect” and similar expressions as they relate to the Company, including: ‎the benefits of RYAH’s user-generated, HIPAA-compliant data to physicians; RYAH ‎shortly initiate its launch in Europe; RYAH plans to roll-out several other clinical delivery mechanisms; and the results users may receive from using RYAH; are intended to identify forward-looking information. All statements other than statements of historical fact may be forward-looking information. Such statements reflect the Company’s current views and intentions with respect to future events, and current information available to the Company, and are subject to certain risks, uncertainties and assumptions. Many factors could cause the actual results, performance or achievements that may be expressed or implied by such forward-looking information to vary from those described herein should one or more of these risks or uncertainties materialize. These factors include, without limitation: the general business and economic conditions in the regions in which the Company operates; the ability of the Company to execute on key priorities, including the successful completion of acquisitions, business retention, and strategic plans and to attract, develop and retain key executives; difficulty integrating newly acquired businesses; the ability to implement business strategies and pursue business opportunities; disruptions in or attacks (including cyber-attacks) on the Company’s information technology, internet, network access or other voice or data communications systems or services; the evolution of various types of fraud or other criminal behavior to which the Company is exposed; the failure of third parties to comply with their obligations to the Company or its affiliates; the impact of new and changes to, or application of, current laws and regulations; legal and regulatory risks inherent in the cannabis industry; risks relating to the regulatory landscape in certain countries and enforcement related to cannabis, including political risks; risks relating to anti-money laundering laws and regulation; other governmental and environmental regulation; public opinion and perception of the cannabis industry; risks related to proprietary intellectual property and potential infringement by third parties; risks inherent in an agricultural business; risks associated to cannabis products manufactured for human consumption including potential product recalls; a novel business model; granting of permits and licenses in a highly regulated business; the overall difficult litigation environment, including in the United States; increased competition; changes in foreign currency rates; increased funding costs and market volatility due to market illiquidity and competition for funding; the availability of funds and resources to pursue operations; critical accounting estimates and changes to accounting standards, policies, and methods used by the Company; the occurrence of natural and unnatural catastrophic events and claims resulting from such events; and the risk associated with a business in the cannabis industry. Should any factor affect the Company in an unexpected manner, or should assumptions underlying the forward-looking information prove incorrect, the actual results or events may differ materially from the results or events predicted. Any such forward-looking information is expressly qualified in its entirety by this cautionary statement. Moreover, the Company does not assume responsibility for the accuracy or completeness of such forward-looking information. The forward-looking information included in this press release is made as of the date of this press release and the Company undertakes no obligation to publicly update or revise any forward-looking information, other than as required by applicable law.

For further information, please contact: 

  Stephen Hart
  Investor Relations
  917-658-7878
  invest@ryah.com

GlobeNewswire is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

IT Industry

IDEX begins deliveries of its dual-interface sensor to world class electronics manufacturer

GlobeNewswire

Published

on

Reading Time: 1 minute

Oslo, Norway, 15 October 2019: IDEX Biometrics ASA, a leading provider of advanced fingerprint identification and authentication solutions, has received a purchase order and initiated production ramp preparations to fulfill a multi-year order commitment signed with a leading provider of global financial news and IT services, as announced in April this year.

As part of this multimillion-dollar commitment IDEX is supplying its dual-interface sensors to one of the world’s largest electronics manufacturing service companies in order to qualify their manufacturing process; a critical step in any ramp-up process.

Stan Swearingen, CEO of IDEX Biometrics comments: “This is an exciting time for IDEX as we gear up volume production with our partners in what will be a cutting-edge, secure access solution. We now expect a regular flow of purchase orders from this customer and look forward to being an integral part of the rollout of their enhanced biometric security solutions”.

For further information contact:
Stuart Hunt, Head of Investor Relations & Communications
+44 (0)1276 534 632

About IDEX Biometrics
IDEX Biometrics ASA (OSE: IDEX) is the leading provider of fingerprint identification technologies offering simple, secure and personal authentication for all. We help people make payments, prove their identity, gain access to information, unlock devices or gain admittance to buildings with the touch of a finger. We invent, engineer and commercialize these secure, yet incredibly user-friendly solutions. Our total addressable market represents a fast-growing multi-billion-unit opportunity.

For more information, visit www.idexbiometrics.com and follow @IDEXBiometrics

This information is subject to the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.

Continue Reading

IT Industry

Global e∙dentity™ files its third formal USPTO 37CFR1.290 request in six months against Apple AAPL (NASDAQ)

GlobeNewswire

Published

on

Reading Time: 1 minute

WILMINGTON, Del., Oct. 15, 2019 (GLOBE NEWSWIRE) — Global e∙dentity™, founded by Robert Adams, U.S. Navy veteran who along with the most amazing engineers & team, have developed and patented the next generation of identity protocol methods, has now filed its third 37CFR1.290 request with the USPTO within in six months against Apple; the formal third-party review request with the USPTO is in opposition to Apple newest patent application 16/262032 published on September 12, 2019. Adams stated that Global e∙dentity™ had “no choice, and once again, file a new third-party action with the USPTO in response to Apple’s latest published patent application.”  USPTO new third party filing is noted on the Global e·dentity™ website: https://www.globaledentity.com/third-party-review-uspto3/

Global e∙dentity™ was featured on Featured on KRON4 — San Francisco Bay Area’s Local TV www.globaledentity.com/2019/06/22/kron4-apple-intellectual-property-theft-and-patent-violations with regards the first of two third-party actions with the USPTO against Apple.  Adams continued, “We are indeed flattered that Apple has now filed, not one, not two, but now a third patent application based on our already patented technology 10,135,822 Biometric authentication of individuals utilizing characteristics of bone and blood vessel structures and its continuation patents.   Having said that, the key question remains: Why did Apple fail to inform the USPTO they had in their possession per their request, all of our trade secrets and provisional patent as early as March/April 2017 when negotiations started between representatives of Apple and Global e∙dentity?”

Global e·dentity™, is young well-funded tech start-up company with national security applications in mind; providing secure multi-factor biometric and digital identity solutions. For more information, visit www.globaledentity.com. Global e·dentity™ and product are either registered trademarks or trademarks of You are the ID ™ LLC in the United States and/or other countries.

For more information, press only: Sophia Miller  sophiam@globaledentity.com

Continue Reading

IT Industry

Digia Plc will publish its business review January-September 2019 on October 31, 2019

GlobeNewswire

Published

on

Reading Time: 1 minute

Digia Plc
Investor News
15 October 2019 at 09:00 am


Digia Plc will publish its business review January-September 2019 on Thursday 31 October at 8:00 am EET (GMT +2). After the publishing the report is available on: https://digia.com/en/investors/stock-exchange-releases/.

Timo Levoranta, President & CEO, and Kristiina Simola, CFO, will present the financial results in Finnish at an analyst and press conference in Helsinki on Thursday, October 31, 2019 at 11.00 am (EET). The conference will take place at Business Meeting Park in Helsinki (address: Forum, Mannerheimintie 20 B, 6th floor. Entrance from the glass corner of Mannerheimintie and Simonkatu).

The material and presentation for the event will be available from 11 am on October 31, 2019 in the Investors section of the company’s website: www.digia.com/en/investors/reports-and-presentations.

Digia Oyj
Timo Levoranta, CEO


Additional information:

Kristiina Simola, CFO, tel. +358 40 756 3132

Distribution:
Nasdaq Helsinki
Key media
digia.com

Digia is a software and service company that helps its customers renew themselves digitally. There are more than 1,200 of us working at Digia. Our roots are in Finland and we operate with our customers in Finland and abroad. world. We are building a world in which digitalisation makes a difference. Digia net sales were EUR 112.1 million in 2018. The company is listed on Nasdaq Helsinki (DIGIA). digia.com

Continue Reading

Font Resizer

Subscribe to PICANTE via Email

Enter your email address to subscribe to PICANTE and receive notifications of new posts by email.

Follow us on Facebook

Read more from our authors

Follow our Tweets

Trending

Please turn AdBlock off